Exemestane 25 mg administered once each day was evaluated in the randomized double-blind, multicenter, multinational comparative examine As well as in two multicenter solitary-arm scientific tests of postmenopausal women with State-of-the-art breast most cancers who had disease development following therapy with tamoxifen for metastatic disease or